![]() |
Volumn 41 Online, Issue , 2010, Pages
|
LSFG findings of proliferative diabetic retinopathy after intravitreal injection of bevacizumab.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
DIAGNOSTIC AGENT;
MONOCLONAL ANTIBODY;
ADULT;
ARTICLE;
BLOOD FLOW;
CASE REPORT;
CHOROID;
DIABETIC RETINOPATHY;
DRUG EFFECT;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
INTRAVITREAL DRUG ADMINISTRATION;
LASER;
MALE;
PATHOPHYSIOLOGY;
PILOT STUDY;
RETINA BLOOD VESSEL;
RETINA NEOVASCULARIZATION;
SUBRETINAL NEOVASCULARIZATION;
TREATMENT OUTCOME;
VASCULARIZATION;
CHOROIDAL NEOVASCULARIZATION;
DRUG EFFECTS;
LASER DOPPLER FLOWMETRY;
OPTIC DISK;
PROCEDURES;
RETINAL NEOVASCULARIZATION;
ADULT;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
CHOROID;
CHOROIDAL NEOVASCULARIZATION;
DIABETES MELLITUS, TYPE 1;
DIABETIC RETINOPATHY;
HUMANS;
INTRAVITREAL INJECTIONS;
LASERS;
MALE;
PILOT PROJECTS;
REGIONAL BLOOD FLOW;
RETINAL NEOVASCULARIZATION;
RETINAL VESSELS;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL, HUMANIZED;
BEVACIZUMAB;
LASER-DOPPLER FLOWMETRY;
OPTIC DISK;
|
EID: 79952474736
PISSN: None
EISSN: 19382375
Source Type: Journal
DOI: 10.3928/15428877-20101124-11 Document Type: Article |
Times cited : (22)
|
References (0)
|